Curative resection for hilar cholangiocarcinoma: Does adjuvant therapy impact overall survival? A multi-institution analysis from the U.S. Extrahepatic Biliary Malignancy Consortium.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Bradley Krasnick, Linda Jin, Jesse Davidson, Cecilia Grace Ethun, Timothy M. Pawlik, George A. Poultsides, Thuy Tran, Kamran Idrees, Chelsea A Isom, Sharon M. Weber, Ahmed I. Salem, William G. Hawkins, Steven M. Strasberg, Robert C. G. Martin, Charles Raben Scoggins, Perry Shen, Harveshp Mogal, Carl Richard Schmidt, Shishir Kumar Maithel, Ryan C. Fields, Extrahepatic Biliary Tumors
Institutions: Washington University in St. Louis, Emory University, Winship Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Stanford Medicine, Stanford University, Vanderbilt University, Vanderbilt University Medical Center, University of Wisconsin–Madison, Norton Healthcare, Norton Hospital, University of Louisville, Wake Forest University Health Sciences, Wake Forest University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591399522